CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | Evans John M. CEO | Sale 10b5-1 | −22,094 | $28.27 | $625K | 989,573 |
| 2026-01-30 | Evans John M. CEO | Sale 10b5-1 | −2,906 | $29.00 | $84K | 986,667 |
| 2026-01-30 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 68,672 | ||
| 2026-01-29 | Evans John M. CEO | Option exercise 10b5-1 | +19,336 | $0.67 | $13K | 1,006,003 |
| 2026-01-29 | Evans John M. CEO | Option exercise 10b5-1 | +5,664 | $0.67 | $4K | 1,011,667 |
| 2026-01-29 | Evans John M. CEO | Sale 10b5-1 | −16,333 | $29.19 | $477K | 995,334 |
| 2026-01-29 | Evans John M. CEO | Sale 10b5-1 | −8,667 | $29.74 | $258K | 986,667 |
| 2026-01-29 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,336 | 0 | ||
| 2026-01-29 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,664 | 93,672 | ||
| 2026-01-22 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −6,198 | $35.00 | $217K | 34,813 |
| 2026-01-22 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,371 | $34.00 | $47K | 95,667 |
| 2026-01-20 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −3,034 | $30.12 | $91K | 41,011 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −2,111 | $33.62 | $71K | 113,556 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −15,959 | $34.72 | $554K | 97,597 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −559 | $35.40 | $20K | 97,038 |
| 2025-12-31 | Emany Sravan Kumar Chief Financial Officer | Sale 10b5-1 | −6,294 | $27.10 | $171K | 73,706 |
| 2025-12-31 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,254 | $27.10 | $34K | 115,667 |
| 2025-12-31 | Simon Amy Chief Medical Officer | Grant or award | +12,500 | 77,364 | ||
| 2025-10-27 | FMR LLC 10% owner | Sale | −459 | $26.68 | $12K | 14 |
| 2025-10-06 | FMR LLC 10% owner | Gift | −1,232,434 | 841,231 |
Page 4 of 32 · 630 trades